Shopping Cart
- Remove All
- Your shopping cart is currently empty
Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate, combines a Thalidomide-based cereblon ligand with a two-unit PEG linker for use in PROTAC technology[1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $84 | 5 days | |
5 mg | $137 | 5 days | |
10 mg | $196 | 5 days |
Description | Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate, combines a Thalidomide-based cereblon ligand with a two-unit PEG linker for use in PROTAC technology[1]. |
In vitro | PROTACs consist of two distinct ligands connected by a linker: one ligand targets an E3 ubiquitin ligase, while the other targets a specific protein. They utilize the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
Alias | Thalidomide-NH-PEG2-C2-NH2 hydrochloride |
Molecular Weight | 440.88 |
Formula | C19H25ClN4O6 |
Cas No. | 2245697-87-2 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.